Intercept Pharmaceuticals Inc. (ICPT)'s Positive Liver Cure Overshadows Dismal Second Quarter Results
Intercept Pharmaceuticals Inc.
Intercept Pharmaceuticals Inc. (ICPT)
Market is closed
News
- First
- << Previous
- 31 - 40
- Next >>
NASH a Big Opportunity For Gilead Sciences, Inc. (GILD)
After being a dominant player in the hepatitis C market with its drug Sovaldi, Gilead Sciences, Inc.
Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks
Small-cap picks from individual funds might provide investors with attractive investment options.
Orbimed Advisors Cuts Stake In Intercept Pharmaceuticals Inc (ICPT)
Orbimed Advisors is limiting exposure to Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after selling approximately 81,305 shares in one transaction at $320 a piece, according to a recent Form 4 filing...
Second Wave of Moves from SAC Capital
In another set of filing with the Securities and Exchange Commission, Steven Cohen and his fund, SAC Capital Advisors, have revealed a number of changes to their equity portfolio.
Visium Asset Management Ups Stake in Skyrocketing Intercept Pharmaceuticals Inc (ICPT)
Jacob Gottlieb's Visium Asset Management has increased its stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), according to an amended filing with the SEC. Gottlieb's fund now holds 1.04 million shares...
Steve Cohen, SAC Capital Reveal 5.3% Stake in Intercept Pharmaceuticals
Steve Cohen's SAC Capital has just revealed a 5.3% stake in Intercept Pharmaceuticals Inc (NASDAQ:ICPT), a new filing with the SEC indicates.
Samuel Isaly's Orbimed Advisors Sells Some Intercept Pharmaceuticals Stock at $62.50/Share
Orbimed Advisors, Intercept Pharmaceuticals: Samuel Isaly and his hedge fund, Orbimed Advisors, is focused on healthcare stocks.
Orbimed Downgrades its Position in Intercept Pharmaceuticals
Orbimed Advisors, Intercept Pharmaceuticals: In a recent SEC filing, Samuel Isaly and his hedge fund, Orbimed Advisors, reported decreasing their holding in Intercept Pharmaceuticals Inc (NASDAQ:ICPT...
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
To the average investor, there are many methods market participants can use to analyze publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading activity.
- First
- << Previous
- 31 - 40
- Next >>
Billionaire Hedge Funds
